A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1

Clinical trial NCT07015437 · RECRUITING

Trial details

NCT number: NCT07015437
Sponsor: Cerus Corporation
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2025-09-19
Primary completion: 2026-07-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.